Fluorescent nanorods and nanospheres for real-time in vivo probing of nanoparticle shape-dependent tumor penetration
- PMID: 22113800
- PMCID: PMC3260125
- DOI: 10.1002/anie.201104449
Fluorescent nanorods and nanospheres for real-time in vivo probing of nanoparticle shape-dependent tumor penetration
Figures
Similar articles
-
Surface plasmon modes of gold nanospheres, nanorods, and nanoplates in an organic solvent: phase-transfer from aqueous to organic media.J Colloid Interface Sci. 2011 Jun 15;358(2):317-22. doi: 10.1016/j.jcis.2011.03.041. Epub 2011 Mar 16. J Colloid Interface Sci. 2011. PMID: 21470619
-
Endosomal Confinement of Gold Nanospheres, Nanorods, and Nanoraspberries Governs Their Photothermal Identity and Is Beneficial for Cancer Cell Therapy.Adv Biosyst. 2020 Apr;4(4):e1900284. doi: 10.1002/adbi.201900284. Epub 2020 Feb 9. Adv Biosyst. 2020. PMID: 32293165
-
Chiral Au₂₅ nanospheres and nanorods: synthesis and insight into the origin of chirality.Nano Lett. 2011 Sep 14;11(9):3963-9. doi: 10.1021/nl202288j. Epub 2011 Aug 11. Nano Lett. 2011. PMID: 21834520
-
Rod-shaped mesoporous silica nanoparticles for nanomedicine: recent progress and perspectives.Expert Opin Drug Deliv. 2018 Sep;15(9):881-892. doi: 10.1080/17425247.2018.1517748. Epub 2018 Sep 7. Expert Opin Drug Deliv. 2018. PMID: 30173560 Review.
-
Dendrimer-nanoparticle conjugates in nanomedicine.Nanomedicine (Lond). 2015;10(6):977-92. doi: 10.2217/nnm.14.196. Nanomedicine (Lond). 2015. PMID: 25867861 Review.
Cited by
-
Nanotechnology-based delivery systems to overcome drug resistance in cancer.Med Rev (2021). 2024 Feb 20;4(1):5-30. doi: 10.1515/mr-2023-0058. eCollection 2024 Feb. Med Rev (2021). 2024. PMID: 38515777 Free PMC article. Review.
-
Nanomaterial-encapsulated STING agonists for immune modulation in cancer therapy.Biomark Res. 2024 Jan 7;12(1):2. doi: 10.1186/s40364-023-00551-z. Biomark Res. 2024. PMID: 38185685 Free PMC article. Review.
-
Vasculature organotropism in drug delivery.Adv Drug Deliv Rev. 2023 Oct;201:115054. doi: 10.1016/j.addr.2023.115054. Epub 2023 Aug 15. Adv Drug Deliv Rev. 2023. PMID: 37591370 Review.
-
Recent Studies and Progress in the Intratumoral Administration of Nano-Sized Drug Delivery Systems.Nanomaterials (Basel). 2023 Jul 31;13(15):2225. doi: 10.3390/nano13152225. Nanomaterials (Basel). 2023. PMID: 37570543 Free PMC article. Review.
-
Cell-Penetrating Peptide-Based Delivery of Macromolecular Drugs: Development, Strategies, and Progress.Biomedicines. 2023 Jul 12;11(7):1971. doi: 10.3390/biomedicines11071971. Biomedicines. 2023. PMID: 37509610 Free PMC article. Review.
References
-
- Chauhan VP, Stylianopoulos T, Boucher Y, Jain RK. Annu Rev Chem Biomol Eng. 2011;2:281. - PubMed
- Pluen A, Boucher Y, Ramanujan S, McKee TD, Gohongi T, di Tomaso E, Brown EB, Izumi Y, Campbell RB, Berk DA, Jain RK. Proc Natl Acad Sci USA. 2001;98:4628. - PMC - PubMed
- Popović Z, Liu W, Chauhan VP, Lee J, Wong C, Greytak AB, Insin N, Nocera DG, Fukumura D, Jain RK, Bawendi MG. Angew Chem. 2010;122:8831. - PMC - PubMed
- Angew Chem Int Ed. 2010;49:8649. - PubMed
-
- Weeks ER, Gisler T, Kaplan PD, Weitz DA. Phys Rev Lett. 2000;85:888. - PubMed
- Deen WM. AIChE J. 1987;33:1409.
- Mason TG, Ganesan K, van Zanten JH, Wirtz D, Kuo SC. Phys Rev Lett. 1997;79:3282.
- McKee TD, Grandi P, Mok W, Alexandrakis G, Insin N, Zimmer JP, Bawendi MG, Boucher Y, Breakefield XO, Jain RK. Cancer Res. 2006;66:2509. - PubMed
Publication types
MeSH terms
Grants and funding
- 1U54-CA119349/CA/NCI NIH HHS/United States
- R01-CA085140/CA/NCI NIH HHS/United States
- R01 CA126642-03/CA/NCI NIH HHS/United States
- R01 CA085140/CA/NCI NIH HHS/United States
- P01 CA080124-10/CA/NCI NIH HHS/United States
- R01 CA115767-05/CA/NCI NIH HHS/United States
- R01-CA115767/CA/NCI NIH HHS/United States
- P01-CA080124/CA/NCI NIH HHS/United States
- R01-CA096915/CA/NCI NIH HHS/United States
- U54 CA119349/CA/NCI NIH HHS/United States
- R01 CA096915-09/CA/NCI NIH HHS/United States
- U54 CA119349-05/CA/NCI NIH HHS/United States
- R01 CA115767/CA/NCI NIH HHS/United States
- R01 CA126642/CA/NCI NIH HHS/United States
- R01 CA085140-10/CA/NCI NIH HHS/United States
- P01 CA080124/CA/NCI NIH HHS/United States
- R01-CA126642/CA/NCI NIH HHS/United States
- R01 CA096915-08/CA/NCI NIH HHS/United States
- R01 CA096915/CA/NCI NIH HHS/United States
- R01 CA126642-04/CA/NCI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources